The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

It has been about a month since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 11.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

This was the stock's second consecutive day of gains.

What if you'd invested in Catalyst Pharmaceutical (CPRX) ten years ago? It may not have been easy to hold on to CPRX for all that time, but if you did, how much would your investment be worth today?

FIRDAPSE boosts Catalyst's strong Q1 2025 results, beating forecasts. With 15–20% growth projected, see why analysts rate ...

Catalyst Pharmaceuticals has announced the appointment of Dr. William T. Andrews as Chief Medical Officer, who will report to President and CEO Richard J. Daly. Dr. Andrews, who succeeds retiring ...

Catalyst Pharmaceuticals will announce Q4 and 2024 financial results on February 26, followed by a conference call on February 27. Catalyst Pharmaceuticals, Inc. announced that it will release its ...

CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of ...

Nov. 06, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for the third quarter of 2024 and provided a ...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently announced the appointment of William T. Andrews, MD, as Chief Medical Officer, a move that coincides with a 13% rise in the company's share price over ...